WATCH TV LIVE

NEWSMAX TV HEALTH FINANCE WORLD

Tags: epilepsy | drug | lundbeck | sabril

Epilepsy Treatment for Kids

Monday, 28 October 2013 03:59 PM EDT

Danish pharmaceutical group Lundbeck has won approval in the United States of its epilepsy drug, Sabril, to be used in children aged 10 years and older.

Lundbeck said in a statement the United States Food and Drug Administration (FDA) had approved Sabril as an add-on therapy for the treatment of refractory complex partial seizures in children who have inadequately responded to several other treatments.

Click Here to comment on this article

Sign up for Newsmax’s Daily Newsletter

Receive breaking news and original analysis - sent right to your inbox.

Yes, Send Me News Alerts via email

(Optional for Local News)

Privacy: We never share your email address.

Join the Newsmax Community

Read and Post Comments
Please review Community Guidelines before posting a comment.

Find Your Condition

Cancer	Heart Disease
Obesity	Arthritis
Alzheimer's/Dementia	Digestive Problems
Cold/Flu	Depression
Allergies	High Cholesterol
Chronic Pain	Thyroid Disorders
Menopause	Osteoporosis
Autism	Anxiety
High Blood Pressure	Diabetes

More Conditions

TOP

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.